Carregant...
Long-Term Survival in Gastroesophageal Junction Adenocarcinoma: Ramucirumab
We report a case of long-term survival with complete response of liver metastases within RAINBOW, a randomized, controlled trial of ramucirumab 8 mg/kg intravenously (days 1, 15) versus placebo, both plus paclitaxel 80 mg/m(2) intravenously (days 1, 8, 15), every 4 weeks in patients with previously...
Guardat en:
| Publicat a: | Case Rep Gastroenterol |
|---|---|
| Autors principals: | , , , , |
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
S. Karger AG
2018
|
| Matèries: | |
| Accés en línia: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6167727/ https://ncbi.nlm.nih.gov/pubmed/30283289 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1159/000490906 |
| Etiquetes: |
Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|